Atlas Trials

Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects

Clinical trial NCT07697443 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07697443
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2026-08-01
Primary completion
2029-08-01
Enrollment
306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.